Preventive Analgesia in Multiparas Undergoing Induction of Labour

• Pain scores (VAS) remain 3 or less [ Time Frame: throughout the first stage of labor ] [ Designated as safety issue: No ]
  

• Bupivacaine consumption [ Time Frame: during labour ] [ Designated as safety issue: No ]
  
• Urinary creatinine to cortisol ratio [ Time Frame: during labour ] [ Designated as safety issue: No ]
  
• Neonatal outcome [ Time Frame: at delivery ] [ Designated as safety issue: No ]
  
• Obstetric outcome [ Time Frame: at delivery ] [ Designated as safety issue: No ]
  

Labour induces a well-documented stress response in both mother and fetus. Pain, anxiety and stress associated with labour result in the activation of the sympathetic nervous system, which increases plasma catecholamine concentrations with a resultant increase in cardiac output, peripheral vascular resistance and eventually, reduction in utero-placental perfusion. One aspect that has not been addressed in the literature is the role of preventive analgesia in labour. We believe that the use of preventive epidural analgesia will improve the quality of labour pain, increase maternal satisfaction and reduce the stress response in labour.

The multiparous parturients that are scheduled for elective inductions of labour will be offered preventive epidural analgesia. Upon placing the epidural, patients will receive, in a double blind fashion, one of two possible epidural drug regimens, which are a saline placebo or 0.0625% bupivacaine with 2 micrograms of fentanyl per millilitre. The patient then undergoes routine induction and management of labour. At any point after induction of labour, patients in either group can request analgesia. Upon request for analgesia the standard epidural loading dose and infusion with PCEA is initiated. The primary outcome will be the success of analgesia (Verbal Analogue Scale of 3 or less) during the first stage of labor, from first request of epidural analgesia to full dilatation.